May 27, 2005-- Guidant Corporation (Indianapolis, Indiana) sent a letter to physicians this week informing them about a potential shorting defect in certain models of the company's PRIZM 2 DR ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...

For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...

The S-ICD system with no leads in the heart When Boston Scientific announced its acquisition of Cameron Health in early 2012, it proclaimed that Cameron's subcutaneous ICD device with no leads in the ...

Please provide your email address to receive an email when new articles are posted on . An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes ...

Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.

Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices. Among patients hospitalized with ...

Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...